Phillip Parente COSA-IPOS Joint Scientific Meeting 2012

Abstracts this author is presenting:

• Cabazitaxel for patients with metastatic castration-resistant prostate cancer (mCRPC): Interim results from the Australian early access program [NCT01254279] — COSA Posters: Education and Supportive Care